Weilbach Christian, Hoppe Christian, Karst Matthias, Winterhalter Michael, Raymondos Konstantinos, Schultz Arthur, Rahe-Meyer Niels
Department of Anesthesiology, Intensive Care, Emergency Medicine and Pain Therapy, St. Josefs-Hospital Cloppenburg, Cloppenburg.
Clinic for Anesthesiology and Operational Intensive Care, Franziskus Hospital Bielefeld, Bielefeld.
J Pain Res. 2017 May 10;10:1105-1109. doi: 10.2147/JPR.S131029. eCollection 2017.
Topical anesthesia is used to control pain associated with many procedures in medicine. Today, the product most commonly applied for topical anesthesia in Germany is EMLA (lidocaine/prilocaine). However, since prilocaine is a methemoglobin-inducing agent, there are limitations to its use, especially in neonates and infants. The aim of this study was to evaluate the effect of prilocaine and lidocaine as well as propylene glycol, a penetration enhancer, and trometamol, a buffer substance, in anesthetic creams.
Twenty-nine healthy adults participated in this study. Standardized creams with eight different compositions were applied and left for 20, 40 or 60 min. After exposure to standardized painful stimuli (blunt/sharp with pressures of 0.2, 0.4 or 0.8 N), subjects rated the experimental pain using a visual analog scale.
Significant results were only found with an exposure time of 60 min and a stamp pressure of 0.8 N. At a concentration of 20%, lidocaine was more effective compared to placebo and equally effective compared to lidocaine/prilocaine in controlling pain. The analgesic effect of the cream containing lidocaine 10% and additional trometamol was significantly superior to that of placebo and non-inferior to that of lidocaine/prilocaine. In this study, the penetration enhancer propylene glycol did not accelerate the onset of the analgesic effect. In contrast, the addition of trometamol (Tris/THAM) accelerated the onset of the effect compared to the native formulation (at 0.4 and 0.8 N). In all of the adult subjects of this study, the minimum exposure time was 60 min for any of the tested topical anesthetic creams.
The results of this study indicate that a cream containing 20% lidocaine, 38% trometamol and 10% propylene glycol may be used as an alternative to lidocaine/prilocaine with a comparable effect and without the need to extend exposure time.
局部麻醉用于控制医学中许多操作相关的疼痛。如今,德国最常用于局部麻醉的产品是复方利多卡因乳膏(利多卡因/丙胺卡因)。然而,由于丙胺卡因是一种可诱导高铁血红蛋白的药物,其使用存在局限性,尤其是在新生儿和婴儿中。本研究的目的是评估丙胺卡因、利多卡因以及渗透促进剂丙二醇和缓冲物质氨丁三醇在麻醉乳膏中的作用。
29名健康成年人参与了本研究。应用了具有八种不同成分的标准化乳膏,并留置20、40或60分钟。在暴露于标准化疼痛刺激(钝性/锐性,压力为0.2、0.4或0.8牛顿)后,受试者使用视觉模拟量表对实验性疼痛进行评分。
仅在暴露时间为60分钟且压痕压力为0.8牛顿时发现显著结果。在浓度为20%时,利多卡因在控制疼痛方面比安慰剂更有效,且与利多卡因/丙胺卡因效果相当。含有10%利多卡因和额外氨丁三醇的乳膏的镇痛效果明显优于安慰剂,且不劣于利多卡因/丙胺卡因。在本研究中,渗透促进剂丙二醇并未加速镇痛效果的起效。相比之下,与原始配方相比,添加氨丁三醇(三羟甲基氨基甲烷)加速了起效(在0.4和0.8牛顿时)。在本研究的所有成年受试者中,任何测试的局部麻醉乳膏的最短暴露时间均为60分钟。
本研究结果表明,含有20%利多卡因、38%氨丁三醇和10%丙二醇的乳膏可作为利多卡因/丙胺卡因的替代品,效果相当且无需延长暴露时间。